At Chyrscapital they like companies with large presence in domestic pharma market. They like IPCA Labs because it is a stable growth story and expect a sustainable growth of 18-20 percent growth for the long-term.
first published: Jun 6, 2013 02:10 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Slips Over 150 Points From Day's High But Gains For 6th Day| IT Stocks Surge|Closing Bell Live
Jigar Mistry flags potential risk to markets and what investors need to be cautious about
Will Nifty Clinch All-Time High As GIFT Nifty Signals Big Gap Up? HUL Q2 Today| Opening Bell Live
EU Ramps Up Ukraine Aid, Tomahawk Missiles as Trump-Putin Ceasefire Talks Risk Donbas Territory Loss
